News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Blume-Jensen Peter
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/23/2023 |
4
| Blume-Jensen Peter (President and CEO) has filed a Form 4 on Acrivon Therapeutics, Inc.|
Txns:
| Granted 493,994 shares
@ $0 |
|
| 06/01/2023 |
4
| Blume-Jensen Peter (President and CEO) has filed a Form 4 on Acrivon Therapeutics, Inc.|
Txns:
| Exercised 33,605 options to buy
@ $3.88, valued at
$130.4k
|
|
| 11/16/2022 |
4
| Blume-Jensen Peter (President and CEO) has filed a Form 4 on Acrivon Therapeutics, Inc.|
Txns:
| Granted 934,731 shares
@ $0
Granted 503,419 shares
@ $0
Granted 60,090 shares
@ $0
Granted 26,707 shares
@ $0
Granted 180,269 options to buy
@ $12.5, valued at
$2.3M
Granted 80,120 options to buy
@ $12.5, valued at
$1M
|
|
|
|